Apigenin (Expanded) for Anxiety Relief

Research suggests that apigenin, a flavonoid found in chamomile and other plants, may have modest anxiety-relieving properties, supported by a mix of mechanistic reviews, animal studies, and at least one human clinical trial. A randomized controlled trial found that chamomile extract — with apigenin as a key active compound — produced statistically significant reductions in anxiety scores compared to placebo in adults with mild to moderate generalized anxiety disorder, while multiple reviews point to apigenin's ability to interact with GABA receptors in ways that partially overlap with how anti-anxiety medications work, though some mechanisms appear to operate through distinct pathways not yet fully characterized. The overall body of evidence leans supportive in direction, but important limitations apply: much of the mechanistic research comes from laboratory and animal models rather than human trials, the single RCT was small and focused on chamomile extract rather than isolated apigenin, and the combined effects of consuming multiple flavonoids together — as typically occurs in dietary sources — remain poorly understood. Studies indicate that chamomile is generally well tolerated, though individuals with allergies to plants in the daisy family and those in specific populations such as breastfeeding mothers should be aware of potential safety considerations, and researchers consistently call for larger, more rigorous clinical trials before firm conclusions can be drawn.